Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO

Abstract Background Disease-modifying drug use necessitates better Alzheimer disease (AD) detection. Mild cognitive impairment (MCI) leverages cognitive decline to identify the risk group; similarly, mild behavioral impairment (MBI) leverages behavioral change. Adding MBI to MCI improves dementia pr...

詳細記述

書誌詳細

出版年:	Molecular Neurodegeneration
主要な著者:	Zahinoor Ismail, Rebeca Leon, Byron Creese, Clive Ballard, Philippe Robert, Eric E. Smith
フォーマット:	論文
言語:	英語
出版事項:	BMC 2023-07-01
主題:	Alzheimer’s disease Mild cognitive impairment Prodromal disease Neuropsychiatric symptoms Mild behavioral impairment Biomarkers
オンライン･アクセス:	https://doi.org/10.1186/s13024-023-00631-6